Venture capital firm profile
Medicxi
Medicxi creates and finances biotechnology companies developing new medicines, using asset-focused investment to support scientific discovery, clinical validation and later-stage therapeutic development.

Any stage
Drug-development focus from discovery through clinical proof of concept, pivotal studies, registration and launch. Early-stage financing favors asset-focused companies with outsourced operations and minimal fixed costs; later-stage activity targets companies that have reached clinical proof of concept. Medicxi's policy excludes oil and gas exploration, pornography, offensive armaments and tobacco products; individual funds may apply additional screens.
Healthcare & Life Sciences
Drug-development focus from discovery through clinical proof of concept, pivotal studies, registration and launch. Early-stage financing favors asset-focused companies with outsourced operations and minimal fixed costs; later-stage activity targets companies that have reached clinical proof of concept. Medicxi's policy excludes oil and gas exploration, pornography, offensive armaments and tobacco products; individual funds may apply additional screens.
Sources checked
Healthcare & Life Sciences
As of
Sources checked
Medicxi is a life-sciences investment firm with offices in London, Geneva and Jersey, established in 2016 by the former Index Ventures life-sciences team. It creates and backs drug-development companies, pairing asset-focused early financing with support for businesses progressing beyond clinical proof of concept.
Editorial profile by MoneyMakers. Sources reviewed . Profile source.
Loading profile details…
Investment sectors
Healthcare & Life Sciences · Investment sectors
As of 2026-11-13
Medicxi official sourceMedicxi official sourceMedicxi official sourceMedicxi official sourceMedicxi official sourceMedicxi official sourceLoading recent changes…